Skip to main content
. Author manuscript; available in PMC: 2012 Feb 8.
Published in final edited form as: Brain Res Dev Brain Res. 2005 Apr 9;157(1):8–18. doi: 10.1016/j.devbrainres.2005.02.017

Fig. 6.

Fig. 6

(A) Plots depicting the neurogenetic pattern of cells that, in adulthood, contain CalB, GRP, SP, VIP, and VP. The embryonic day of the BrdU injection is indicated along the abscissa. The ordinate indicates the average percentage of cells immunoreactive for the peptide of interest that are also immunoreactive for BrdU. (B) A schematic outlining important developmental milestones of SCN attributes, including those described here (neurogenesis, and the ontogeny of detectable expression of CalB, GRP and SP) as well as elsewhere (neurogenesis [11,13]; VIP-ir [8]; SCN rhythmicity [12,36,49]; GFAP-ir [8]; VP-ir [40]; and RHT innervation [24,31,47]).